NLRP3 and myocardial infarction: NLRP3 inflammasome is upregulated after myocardial infarction, atherosclerosis, ischemic heart disease, diabetic cardiomyopathy, chronic heart failure, and hypertension, and recently, NLRP3 and IL‐1β have also been proposed as new cardiovascular risk biomarkers (Bullón et al., 2017; Liu, Zeng, Li, Mehta, & Wang, 2017).